Meta Information

ID:cerebrolysin

Name:Cerebrolysin

Schema Version:1.5

Alternate Names

• FPF-1070

Intervention Type

therapeutic_agent

Expected Cost Mean

Low Cost:

75

High Cost:

150

Cost Type:

monthly

Description:

Cost for imported drug, not including supplies or physician oversight; not insurance covered.

Summary

Cerebrolysin is a mixture of peptides derived from purified porcine brain proteins that mimics the effects of natural neurotrophic factors. It is proposed to support healthspan by promoting neuronal survival, neurogenesis, and synaptic plasticity, potentially protecting against age-related cognitive decline and neurodegenerative processes. However, its efficacy is primarily studied in acute injury or disease states, not healthy aging.

Purpose

A porcine brain-derived peptide mixture for neuroprotection and cognitive support.

Drug Class

nootropic_peptide_mixture

Drugs In Class

Empty Array

Impact

Score:

3.8

Justification:

Potential for neuroprotection, but lacks evidence for cognitive enhancement in healthy, aging individuals.

Evidence

Grade:

C

Score:

4.5

Justification:

Human trials exist for disease states, but data for healthspan in healthy individuals is absent.

Safety

Score:

6.2

Justification:

Injectable biologic often sourced from unregulated pharmacies, posing purity and administration risks.

Flags

• Not approved by the US FDA for any indication.
• Must be sourced from international pharmacies, raising concerns about product quality and authenticity.
• Risk of infection or injury from improper injection technique.
• Contraindicated in individuals with severe renal impairment or status epilepticus.
• Potential for allergic reactions to porcine-derived proteins.

Verdict

A high-risk, experimental neuro-agent with unproven benefits for healthy aging.

Model

Gemini 3.1 Pro (High)

Delivery

Route:

subcutaneous_injection

Scope:

• systemic

Indication

Focus:

healthspan

Description:

Cerebrolysin is a mixture of peptides derived from purified porcine brain proteins that mimics the effects of natural neurotrophic factors. It is proposed to support healthspan by promoting neuronal s...

Typical Protocol

• Cycles of 5-10ml daily intramuscular injections for 10-20 days, repeated 2-4 times per year.